Rare autoantibodies (anti-PO, anti-Ku, and anti-U1snRNP) should not be overinterpreted for diagnosis without supporting clinical criteria. Resource limitations may delay diagnosis and management in autoimmune conditions. Here, PRB4 is linked to Autoimmunity.